AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $278,769 | -84.2% | 43,841 | -85.0% | 0.00% | -100.0% |
Q1 2024 | $1,760,110 | +3574.2% | 291,409 | +2448.8% | 0.00% | – |
Q3 2023 | $47,904 | -18.7% | 11,433 | -72.8% | 0.00% | – |
Q1 2023 | $58,896 | -29.2% | 41,979 | 0.0% | 0.00% | – |
Q4 2022 | $83,129 | +1.4% | 41,979 | +6.4% | 0.00% | – |
Q3 2022 | $82,000 | -61.7% | 39,443 | -40.1% | 0.00% | – |
Q2 2022 | $214,000 | -9.3% | 65,903 | +17.3% | 0.00% | – |
Q1 2022 | $236,000 | -13.2% | 56,168 | +0.1% | 0.00% | – |
Q4 2021 | $272,000 | +205.6% | 56,107 | +199.2% | 0.00% | – |
Q2 2020 | $89,000 | +29.0% | 18,751 | -8.7% | 0.00% | – |
Q1 2020 | $69,000 | -80.3% | 20,549 | -71.8% | 0.00% | -100.0% |
Q4 2019 | $351,000 | +0.3% | 72,980 | -39.6% | 0.00% | 0.0% |
Q3 2019 | $350,000 | -21.3% | 120,774 | +285.2% | 0.00% | 0.0% |
Q1 2019 | $445,000 | +27.1% | 31,356 | +20.9% | 0.00% | 0.0% |
Q4 2018 | $350,000 | -44.9% | 25,937 | -9.4% | 0.00% | 0.0% |
Q3 2018 | $635,000 | +55.3% | 28,613 | +14.9% | 0.00% | 0.0% |
Q2 2018 | $409,000 | – | 24,907 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $42,827,417 | 3.52% |
TPG GP A, LLC | 12,328,767 | $24,534,246 | 0.48% |
CM Management, LLC | 150,000 | $299 | 0.36% |
Signature Wealth Management Partners, LLC | 87,666 | $174,455 | 0.17% |
Eversept Partners, LP | 830,960 | $1,653,610 | 0.14% |
Tranquilli Financial Advisor LLC | 71,414 | $142,114 | 0.11% |
Hedges Asset Management LLC | 50,000 | $99,500 | 0.09% |
XTX Topco Ltd | 191,502 | $381,089 | 0.08% |
EMC Capital Management | 40,613 | $81 | 0.07% |
Orbimed Advisors | 1,583,490 | $3,151,145 | 0.06% |